Study of Dolutegravir Degradation and Spectroscopic Identification of Products by LCMS, 1H and 13C NMR Techniques
Stability study for dolutegravir bulk drug was performed and the degradation products formed were identified by chromatography (HPLC, LCMS) and spectroscopy (ESI-MS, FTIR, 1H and 13C NMR) techniques. Degradation of the drug in acidic and peroxide environment yielded one common major degradant f ((2,4-difluorophenyl) methanamine) with a mass peak at m/z = 182.44. In addition to this, five more minor degradation products (a, b, c, d and e) were formed. The structure interpretation showed that the drug degraded to its synthetic precursor and no extra structures were formed. Hence, it was suggested that drug dolutegravir should be kept away from acidic and oxygen rich conditions.
Keywordsdolutegravir degradation spectroscopy LCMS, NMR
Conflict of Interest
The authors declare no conflict of interest.
- 1.British National Formulary: BNF 69 (69th Edition), British Medical Association (2015), 429.ISBN 9780857111562.Google Scholar
- 3.N. Mulligan, B. Best, E. Capparelli, et al., in: Conference on Retroviruses and Opportunistic Infections (2016, Boston, MA, USA), Abstract 438.Google Scholar
- 5.G. B. Bhavar, K. B. Aher, R. S. Thorat, et al., Malay. J. Anal. Sci., 19(6), 1156 – 1163 (2015).Google Scholar
- 8.ICH Q2 (R1), Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization, IFPMA, World Health Organization: Geneva (2009).Google Scholar
- 9.M. Nenad, Lovro Selic, and C. Anja, Patent WO2016113372A1 (2016).Google Scholar